-
Originally Posted by Catalyst
The share buy-back should also support/boost the share price over the next couple of months.
Think they will struggle to buy many , there just are not any sellers about at the moment , mAybe if they wanted to buy some back they should not have been so upbeat about their prospects
-
Blue sky potential with this update.
Up up and away
But good luck trying to buy some , there not a single seller
You gotta be in to win
One thing for sure , there a lot of middle aged fat men about, and Diabetes is the new depression, massive market
Last edited by ratkin; 06-09-2012 at 12:17 PM.
-
Originally Posted by ratkin
One thing for sure , there a lot of middle aged fat men about, and Diabetes is the new depression, massive market
Yep - take this new pill. YOu could of course just stop eating sugar but that is never going to happen.
-
Originally Posted by David B
Just as an aside on type II diabetes. The real market for this is not in middle aged fat white men, the burden of this disease falls mostly on South and East Asian (urban Indians in particular) and Polynesians.
Comvita didnt say they were white men !
Dont really need these particular eggs to hatch to be a big benefit to the company. Like they say
"However, we expect there will be increased interest in Comvita products as a
result of the trial.
This research likely to raise the profile of the company a significant amount , its the kind of story that attracts interest from magazines etc
-
Attachment 4135
Still no sign of sellers entering the market
-
Member
Comvita acquires Whanganui apiary business to sure up Manuka honey supply https://www.nzx.com/companies/CVT/announcements/228002
-
Think we should all become beekeepers , Manuka honey is the new gold.
Not sure what to make of the Comvita result , sounds like they on the right track , although not sure i trust them now.
They provided no updates or any indications that there would be supply constraints , although judging by the sell off of the last month or two , plenty of people did know. They could of mentioned it on the update they made (see post above this one)
Stil traditionally the second half result much better and they still very upbeat ,so will give them benefit of the doubt
Last edited by ratkin; 21-11-2012 at 11:50 AM.
-
Member
As owning health shops Comvita products are well presented and very much regarded by the NZ public and Olive Leaf Extract is a top seller regardless of its maybe Diabetes qualities which if proven would take it to a whole new level.
-
I think this result is a failure given expectations set at the the AGM... "Increased EBIT margins" pg.6 of presso.
Some market participants did know about the issues. Unfortunately, those is the know were not told via a NZX announcement.
The company have said they expect to exceed last years result. How can I have any confidence in what they say based on the recent drop in earnings.
-
21-11-2012, 03:08 PM
#100
Member
They sounded positive on the conf call. They said China/Sth Korea/Hong Kong were very strong, although acknowledged Aus/UK were tough. Northern hemisphere winter and holidays such as Chinese new year make for a stronger second half.
They said both their olive leaf product for reducing blood sugar levels, and their cardio-vascular product, have been well received. Apparently Olive Leaf products have previously been seen as just a cold & flu product so this gives them an opportunity to reduce the seasonality of olive leaf sales. CEO also mentioned they were working on a new olive leaf product and a new ingredient platform but wouldn't give any more detail. Because demand is strong they said growing supply will have an immediate impact on bottom line and they're focussing there. Their supply from their latest apiary acquisition is going to come on board shortly (didn't catch the date sorry).
Disc. hold CVT
Tags for this Thread
Posting Permissions
- You may not post new threads
- You may not post replies
- You may not post attachments
- You may not edit your posts
-
Forum Rules
|
|
Bookmarks